1. Home
  2. CHGG vs CPIX Comparison

CHGG vs CPIX Comparison

Compare CHGG & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chegg Inc.

CHGG

Chegg Inc.

N/A

Current Price

$0.58

Market Cap

117.4M

Sector

Real Estate

ML Signal

N/A

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

N/A

Current Price

$5.39

Market Cap

98.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHGG
CPIX
Founded
2005
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.4M
98.3M
IPO Year
2013
2007

Fundamental Metrics

Financial Performance
Metric
CHGG
CPIX
Price
$0.58
$5.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 763.2K
135.6K
Earning Date
11-03-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 88.15
58.70
EPS
★ N/A
N/A
Revenue
★ $376,908,000.00
$42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 16.75
52 Week Low
$0.52
$1.85
52 Week High
$1.56
$9.28

Technical Indicators

Market Signals
Indicator
CHGG
CPIX
Relative Strength Index (RSI) 31.80 44.41
Support Level $0.53 $3.08
Resistance Level $0.68 $6.32
Average True Range (ATR) 0.06 0.75
MACD -0.01 0.01
Stochastic Oscillator 9.36 27.35

Price Performance

Historical Comparison
CHGG
CPIX

About CHGG Chegg Inc.

Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Chegg Skilling; and Academic Services, which derives maximum revenue. Geographically, it derives in United States and International.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Share on Social Networks: